Richard Bafford, MD
Vascular Surgery · Bel Air, MDNPI 1215056254
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Philips North America LLC accounts for 83.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $14,164 and has fallen 74.0% since, to $3,688 in 2025. Among vascular surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $286.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$26K
- Globus Medical$1K
- Cook Medical LLC$916
- Stryker$791
- W. L. Gore & Associates, Inc.$339
- Bard Peripheral Vascular, Inc.$300
- plus $1K from 12 others
What the payments were for
- Consulting fees$16,40053%
- Speaking & faculty fees$9,49431%
- Travel & lodging$2,0497%
- Food & beverage$2,97510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 17 | $25,931 |
| Globus Medical(2 entities) | 12 | $1,275 |
| Cook Medical LLC | 8 | $916 |
| Stryker | 4 | $791 |
| W. L. Gore & Associates, Inc. | 3 | $339 |
| Bard Peripheral Vascular, Inc. | 13 | $300 |
| Medtronic(2 entities) | 10 | $273 |
| Silk Road Medical, Inc. | 4 | $229 |
| Angiodynamics, Inc. | 11 | $176 |
| Cook Incorporated | 1 | $154 |
| Johnson & Johnson | 7 | $139 |
| Boston Scientific | 6 | $120 |
| Inari Medical, Inc. | 2 | $91 |
| Cardinal Health 200 LLC | 5 | $81 |
| Abbott | 2 | $52 |
| Mozarc Medical US LLC | 1 | $30 |
| Eagle Pharmaceuticals, Inc. | 1 | $13 |
| Nipro Medical Corporation | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$16,400
- Spectranetics Undiv$6,044
- IVUS Systems$3,200
- ALIF$745
- EVEREST SPINAL SYSTEM$742
- XLIF$617
- Cook Medical Peripheral Intervention$577
- GORE TAG Conformable Thoracic Endoprosthesis$319
- Cook Medical IAA$154
- ENROUTE Transcarotid Neuroprotection System$125
- ENROUTE Transcarotid Stent$125
- ELLIPSYS VASCULAR ACCESS SYSTEM$121
- Brigade$107
- Pulse$104
How this compares
$30,918 in reported general payments places this provider in the 90th percentile of 104 vascular surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 28 | $29,951 |
| EliquisApixaban | 15 | $20,891 |
| ClopidogrelClopidogrel Bisulfate | 94 | $1,553 |
| Cilostazol | 19 | $399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $139 | $29,95128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 104 vascular surgery providers in Maryland.
Other vascular surgery in Bel Air
- Michael OsgoodBel Air$57K
- Micah GirottiBel Air$35K
- Andre BiuckiansBel Air$24K
- Philip RiveraBel Air$4K
- Peter MackrellBel Air$3K
- Paul McNeillFrederick$302K
- John MartinAnnapolis$172K
- Caitlin HicksBaltimore$88K
- Shahab ToursavadkohiBaltimore$76K
- Jeffrey WangGermantown$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.